Health ❯ Obesity ❯ Treatment Options
Drug Efficacy ATTAIN-2 Trial MET-097i
Regulatory pushback to Novo Nordisk’s bid cleared the path for a cash‑plus‑CVR deal transferring Metsera’s GLP‑1 pipeline to Pfizer.
